Discover 233 paid clinical trials in College Station, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
United Therapeutics
Location:
Code:
NCT04708782
Conditions
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Placebo
Inhaled Treprostinil
Treprostinil Ultrasonic Nebulizer
Sponsor:
Supernus Pharmaceuticals, Inc.
Location:
Code:
NCT04781140
Conditions
Attention-Deficit/Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 48 - 69
Healthy Volunteers: Not accepted
Interventions
100mg SPN-812
Placebo
Sponsor:
AbbVie
Location:
Code:
NCT05814627
Conditions
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Upadacitinib
Adalimumab
Upadacitinib Matching Placebo
Adalimumab Matching Placebo
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT06667076
Conditions
Carcinoma, Non-Small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Amivantamab
Lazertinib
Chemotherapy: Pemetrexed
Chemotherapy: Carboplatin
Sponsor:
NRG Oncology
Location:
Code:
NCT03801876
Conditions
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Esophagectomy
Intensity-Modulated Radiation Therapy
Paclitaxel
Proton Beam Radiation Therapy
Sponsor:
NRG Oncology
Location:
Code:
NCT04804644
Conditions
Metastatic Lung Small Cell Carcinoma
Metastatic Malignant Neoplasm in the Brain
Recurrent Lung Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Memantine Hydrochloride
Neurocognitive Assessment
Stereotactic Radiosurgery
Whole-Brain Radiotherapy